Hyperbaric Oxygen Therapy Devices Market Report 2026

Hyperbaric Oxygen Therapy Devices Market Overview

• Hyperbaric Oxygen Therapy Devices market size has reached to $4.58 billion in 2025 • Expected to grow to $6.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Driving Forces Behind The Growth Of The Hyperbaric Oxygen Therapy Device Market Is Addressing The Diabetes Epidemic • Market Trend: Technological Innovations In Hyperbaric Oxygen Therapy Is Enhancing Treatment Accuracy, Efficiency, And Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hyperbaric Oxygen Therapy Devices Market?

Hyperbaric oxygen therapy (HBOT) devices are specialized medical equipment used to administer hyperbaric oxygen therapy. HBOT involves breathing pure oxygen in a pressurized chamber, allowing the lungs to gather more oxygen than would be possible at normal air pressure. The oxygen supply is delivered to the body's tissues and organs, promoting various therapeutic effects. The main types of hyperbaric oxygen therapy devices are monoplace hyperbaric oxygen therapy devices, multiplace hyperbaric oxygen therapy devices, and topical hyperbaric oxygen therapy devices. Monoplace hyperbaric oxygen therapy devices are chambers designed to accommodate a single patient at a time during treatment sessions. They are used for various applications including wound healing, decompression sickness, infection treatment, gas embolism, and others by hospitals, home care, and others.

What Is The Hyperbaric Oxygen Therapy Devices Market Growth Forecast?

The hyperbaric oxygen therapy devices market size is expected to see strong growth in the next few years. It will grow to $6.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising prevalence of chronic wounds and diabetic ulcers, growing demand for non-invasive therapeutic options, expansion of outpatient and home care services, increasing healthcare investment in advanced therapies, broader clinical indications for hyperbaric oxygen therapy. Major trends in the forecast period include expansion of hyperbaric therapy in chronic wound management, growing adoption of monoplace and portable HBOT devices, increasing use of HBOT in infection and post-surgical recovery, rising demand for home-based and outpatient HBOT solutions, standardization of safety and treatment protocols in hyperbaric centers.

Global Hyperbaric Oxygen Therapy Devices Market Segmentation

1) By Type: Monoplace Hyperbaric Oxygen Therapy Devices, Multiplace Hyperbaric Oxygen Therapy Devices 2) By Application: Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism, Other Applications 3) By End User: Hospitals, Home Care, Other End Users Subsegments: 1) By Monoplace Hyperbaric Oxygen Therapy Devices: Single-Person Chamber Systems, Fixed Monoplace Hbot Chambers, High-Pressure Monoplace Oxygen Chambers 2) By Multiplace Hyperbaric Oxygen Therapy Devices: Two-Person Multiplace Chambers, Multi-Person Chamber Systems (4-10 Persons), Large Multiplace Hyperbaric Chambers, High-Capacity Multiplace Hbot Devices, Advanced Multiplace Oxygen Chambers

What Is The Driver Of The Hyperbaric Oxygen Therapy Devices Market?

The rise in diabetes prevalence is expected to propel the growth of the hyperbaric oxygen therapy device market going forward. Diabetes refers to a group of chronic metabolic disorders characterized by high blood sugar levels over a prolonged period of time. The diabetes cases are on rise due to sedentary lifestyles, unhealthy dietary habits, obesity, genetic predispositions, aging populations, urbanization, and socioeconomic factors. Hyperbaric oxygen therapy devices offer a complementary approach to managing diabetes by facilitating wound healing and tissue repair through the delivery of high-pressure oxygen, thereby potentially reducing the risk of complications such as diabetic foot ulcers and improving overall outcomes for individuals with diabetes. For instance, in June 2023, according to the data published by the Institute for Health Metrics and Evaluation (IHME), a US-based independent population health research center, global diabetes cases are expected to surge from 529 million in 2023 to 1.3 billion by 2050. The global prevalence rate at 6.1%, is projected to rise dramatically. At the super-region level, the highest prevalence rate, currently at 9.3% in North Africa and the Middle East, is forecasted to increase to 16.8% by 2050. Therefore, a rise in diabetes prevalence is driving the hyperbaric oxygen therapy device industry.

Key Players In The Global Hyperbaric Oxygen Therapy Devices Market

Major companies operating in the hyperbaric oxygen therapy devices market are Environmental Tectonics Corporation, Sechrist Industries, Perry Baromedical, HAUX Life Support, Fink Engineering, OxyHelp Industry, Environmental Control Systems, BioBarica, OxyHeal Health Group, Hyperbaric Modular Systems, Baroks Hyperbaric, Oxyvein Hyperbaric Chambers, Hpotech Medical Solutions, Shanghai Baobang Medical Equipment, Jiangsu Haila Resuscitation Equipment, Hyperbaric SAC, Pan America Hyperbarics Manufacturing, Oxymed Hyperbaric Chambers, Vitaeris Hyperbaric Systems, SOS Group Hyperbaric Engineering, ETC Hyperbaric Solutions, OxyAir Hyperbaric Technology

Global Hyperbaric Oxygen Therapy Devices Market Trends and Insights

Major companies operating in the hyperbaric oxygen therapy device market are developing integrating automated logging software into hyperbaric chambers to enhance treatment accuracy, efficiency, and patient care. Integrating automated logging software into hyperbaric chambers helps healthcare professionals accurately capture and monitor treatment parameters in real-time, ensuring precise documentation, streamlined reporting, and enhanced patient safety throughout hyperbaric therapy sessions. For instance, in January 2024, Sechrist Industries Inc., a US-based manufacturer of hyperbaric oxygen chambers and respiratory equipment, launched the 3300 HM Hyperbaric Chamber and the eHEAL System. The 3300 HM Hyperbaric Chamber prioritizes patient comfort and safety with its modern design and innovative Patient Step-in Entry, eliminating the need for a hyperbaric stretcher. Enhanced safety features, user-friendly breathing systems, and versatile compression options cater to diverse medical needs. Meanwhile, the eHEAL System streamlines hyperbaric treatment logging with its intuitive interface, automated data capture, multi-chamber connectivity, and comprehensive logging capabilities. It ensures accuracy, efficiency, and security in treatment records, offering seamless integration with existing systems.

What Are Latest Mergers And Acquisitions In The Hyperbaric Oxygen Therapy Devices Market?

In July 2023, O2 Worx, a UK-based manufacturing and technology company, entered a partnership with Submarine Manufacturing and Products (SMP). The aim of the O2 Worx partnership with SMP is to combine their strengths and expertise to accelerate the growth and deployment of O2 Worx’s hyperbaric oxygen therapy (HBOT) chambers to new markets. Submarine Manufacturing & Products Limited (SMP) is a UK-based company that designs and manufactures high-quality Hyperbaric Oxygen Therapy (HBOT) chambers and related equipment.

Regional Outlook

North America was the largest region in the hyperbaric oxygen therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Hyperbaric Oxygen Therapy Devices Market?

The hyperbaric oxygen therapy (HBOT) device market consists of sales of portable hyperbaric chambers, hyperbaric oxygen concentrators, and hyperbaric oxygen therapy accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.